Edition:
United States

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.65USD
15 Dec 2017
Change (% chg)

$-0.07 (-4.07%)
Prev Close
$1.72
Open
$1.74
Day's High
$1.77
Day's Low
$1.64
Volume
53,024
Avg. Vol
146,378
52-wk High
$5.50
52-wk Low
$1.08

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Kenneth Bate

66 2016 Co-Chairman of the Board

Michael Ross

67 2016 Director, Co-Chairman of the Board of Directors

Jill Milne

49 2016 President, Chief Executive Officer, Co-Founder, Director

Deirdre Cunnane

52 2016 Senior Vice President, General Counsel, Treasurer

Andrew Nichols

56 2016 Chief Scientific Officer